Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067366 · ClinicalTrials.gov registry record · NA
Brief Treatment for Temporomandibular Pain
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT00067366: Completed NA study, sponsored by UConn Health.
NCT00067366 is a NA study that has completed, run by UConn Health. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067366, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
Temporomandibular Disorder (TMD) is a widespread chronic pain condition. Successful psychosocial treatments for TMD have been developed, but the mechanisms by which these treatments achieve their effects are not well known. The goal of this project is to evaluate the possible mechanisms responsible for treatment gains in TMD treatment.
Primary Outcome
Multidimensional pain ratings collected in person every 3 months
Interventions
- BEHAVIORAL Cognitive-Behavioral treatment
- BEHAVIORAL Attention and lifestyle counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2003-10 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT00067366 record still lists
NCT00067366 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive-Behavioral treatment is the first listed.
NCT00067366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00067366 about?
NCT00067366 is a clinical study titled "Brief Treatment for Temporomandibular Pain". Temporomandibular Disorder (TMD) is a widespread chronic pain condition. Successful psychosocial treatments for TMD have been developed, but the mechanisms by which these treatments achieve their effects are not well known. The goal of this project is to evaluate the possible mechanisms responsible ...
What is the current status of trial NCT00067366?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2003-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00067366?
The interventions under investigation include: Cognitive-Behavioral treatment (BEHAVIORAL), Attention and lifestyle counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00067366?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00067366's enrollment target sits among peer trials
116 808th of 2000 higher than 1,191 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia